Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial
Crossref DOI link: https://doi.org/10.1186/s12933-016-0332-6
Published Online: 2016-01-22
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Arbel, Yaron http://orcid.org/0000-0003-4258-6313
,
Klempfner, Robert
Erez, Aharon
Goldenberg, Ilan
Benzekry, Sagit
Shlomo, Nir
Fisman, Enrique Z.
Tenenbaum, Alexander